Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Chris H Polman, Stephen C Reingold, Brenda Banwell, Michel Clanet, Jeffrey A Cohen, Massimo Filippi, Kazuo Fujihara, Eva Havrdova, Michael Hutchinson, Ludwig Kappos, Fred D Lublin, Xavier Montalban, Paul O'Connor, Magnhild Sandberg-Wollheim, Alan J Thompson, Emmanuelle Waubant, Brian Weinshenker, Jerry S Wolinsky, Chris H Polman, Stephen C Reingold, Brenda Banwell, Michel Clanet, Jeffrey A Cohen, Massimo Filippi, Kazuo Fujihara, Eva Havrdova, Michael Hutchinson, Ludwig Kappos, Fred D Lublin, Xavier Montalban, Paul O'Connor, Magnhild Sandberg-Wollheim, Alan J Thompson, Emmanuelle Waubant, Brian Weinshenker, Jerry S Wolinsky

Abstract

New evidence and consensus has led to further revision of the McDonald Criteria for diagnosis of multiple sclerosis. The use of imaging for demonstration of dissemination of central nervous system lesions in space and time has been simplified, and in some circumstances dissemination in space and time can be established by a single scan. These revisions simplify the Criteria, preserve their diagnostic sensitivity and specificity, address their applicability across populations, and may allow earlier diagnosis and more uniform and widespread use.

Copyright © 2011 American Neurological Association.

References

    1. Schumacher FA, Beeve GW, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965;122:552–568.
    1. Poser CM, Paty DW, Scheinberg LC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;1:227–231.
    1. Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT. Neurology. 1988;38:180–185.
    1. Barkhof F, Filippi M, Miller DH, et al. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite MS. Brain. 1997;120:2059–2069.
    1. Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology. 1988;38:1822–1825.
    1. Tintoré M, Rovira A, Martinéz M, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuroradiol. 2000;21:702–706.
    1. Thompson AJ, Montalban X, Barkhof F, et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol. 2000;6:831–835.
    1. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121–127.
    1. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.”. Ann Neurol. 2005;58:840–846.
    1. Dalton CM, Brex PA, Miszkiel KA, et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol. 2002;52:47–53.
    1. CHAMPS Study Group. MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group. Neurology. 2002;59:998–1005.
    1. Barkhof F, Rocca M, Francis G, et al. Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta-1a. Ann Neurol. 2003;53:718–724.
    1. Tintoré M, Rovira A, Rio J, et al. New diagnostic criteria for multiple sclerosis. Application in first demyelinating episode. Neurology. 2003;60:27–30.
    1. Charil A, Yousry TA, Rovaris M, et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation.”. Lancet Neurol. 2006;10:841–852.
    1. Miller DH, Weinshenker BG, Filippi M, et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler. 2008;14:1157–1174.
    1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106–2012.
    1. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202:473–477.
    1. Shimizu J, Hatanaka Y, Hasegawa M, et al. IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology. 2010;75:1423–1427.
    1. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6:805–815.
    1. Carroll WM, Fujihara K. Neuromyelitis optica. Curr Treat Options Neurol. 2010;12:244–255.
    1. Hawkes CH, Giovannoni G. The McDonald Criteria for multiple sclerosis: time for clarification. Mult Scler. 2010;16:566–575.
    1. Swanton JK, Rovira A, Tintoré M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol. 2007;6:677–686.
    1. Rovira A, Swanton J, Tintoré M, et al. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch Neurol. 2009;5:287–292.
    1. Montalban X, Tintoré M, Swanton J, et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology. 2010;74:427–434.
    1. McHugh JC, Galvin PL, Murphy RP. Retrospective comparison of the original and revised McDonald Criteria in a general neurology practice in Ireland. Mult Scler. 2008;14:81–85.
    1. Albertyn C, O'Dowd S, McHugh J, Murphy R. Compliance with McDonald criteria and red flag recognition in a general neurology practice in Ireland. Mult Scler. 2010;16:678–684.
    1. Swanton JK, Fernando K, Dalton CM, et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry. 2006;77:830–833.
    1. Tur C, Tintoré M, Rovira A, et al. Very early scans for demonstrating dissemination in time in multiple sclerosis. Mult Scler. 2008;14:631–635.
    1. Heun R, Kappos L, Bittkau S, et al. Magnetic resonance imaging and early diagnosis of MS. Lancet. 1988;2:1202–1203.
    1. Tas MW, Barkhof F, van Walderveen MA, et al. The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. Am J Neuroradiol. 1995;16:259–264.
    1. Freedman MS, Thompson EJ, Deisenhammer F, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol. 2005;62:865–870.
    1. Masiuan J, Alvarez-Cermeño JC, García-Barragán N, et al. Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS. Neurology. 2006;66:576–578.
    1. Tintoré M, Rovira A, Río J, et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology. 2008;70:1079–1083.
    1. Polman CH, Wolinsky JS, Reingold SC. Multiple sclerosis diagnostic criteria: three years later. Mult Scler. 2005;11:5–12.
    1. Hawker K, O'Connor P, Freedman MS, et al. Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol. 2009;66:460–471.
    1. Montalban X, Sastre-Garriga J, Filippi M, et al. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal. Mult Scler. 2009;15:1459–1465.
    1. Absinta MA, Rocca MA, Moiola L, et al. Brain macro- and microscopic damage in patients with pediatric MS. J Neuro Neurosurg Psychiatry. 2010;81:1357–1362.
    1. Callen DJA, Shroff MM, Branson HM, et al. MRI in the diagnosis of pediatric multiple sclerosis. Neurology. 2009;72:961–967.
    1. Chong HT, Kira J, Tsai CP, et al. Proposed modifications to the McDonald criteria for use in Asia. Mult Scler. 2009;15:887–888.
    1. Chong HT, Li PCK, Singhal BJ, et al. Proposed modification to McDonald diagnostic criteria for Asians with multiple sclerosis. Neurol Asia. 2006;11:87–90.
    1. Lana-Piexoto MA. Devic's neuromyelitis optica: a critical review. Arq Neuropsiquiatr. 2008;66:120–138.
    1. Yeh EA, Chitnis T, Krupp L, et al. Pediatric multiple sclerosis. Nat Rev Neurol. 2009;5:621–631.
    1. Banwell B, Ghezzi A, Bar-Or A, et al. Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol. 2007;6:887–902.
    1. Venkateswaran S, Banwell B. Pediatric multiple sclerosis. Neurologist. 2010;16:92–105.
    1. Hahn JS, Pohl D, Rensel M, et al. Differential diagnosis and evaluation in pediatric multiple sclerosis. Neurology. 2007;68(suppl 2):S13–S22.
    1. Ghassemi R, Antel SB, Narayanan S, et al. Lesion distribution in children with clinically isolated syndromes. Ann Neurol. 2008;63:401–405.
    1. Waubant E, Chabas D, Okuda DT, et al. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Arch Neurol. 2009;66:967–971.
    1. Yeh EA, Weinstock-Guttman B, Ramanathan M, et al. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain. 2009;132(pt 12):3392–3400.
    1. Chabas D, Castillo-Trivino T, Mowry EM, et al. Vanishing MS T2-bright lesions before puberty. Neurology. 2008;71:1090–1093.
    1. Mikaeloff Y, Adamsbaum C, Husson B, et al. MRI prognostic factors for elapse after acute CNS inflammatory demyelination in childhood. Brain. 2004;127:1942–1947.
    1. Ketelslegers IA, Neuteboom RF, Boon M, et al. A comparison of MRI criteria for diagnosing pediatric ADEM and MS. Neurology. 2010;74:1412–1415.
    1. Verhey L, Branson HM, Makhija M, et al. Magnetic resonance imaging features of the spinal cord in pediatric multiple sclerosis: a preliminary study. Neuroradiology. 2010;52:1153–1162.
    1. Krupp LB, Banwell B, Tenembaum S, et al. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007;68(suppl 2):S7–S12.
    1. Callen DJA, Shroff MM, Branson HM, et al. Role of MRI in the differentiation of ADEM from MS in children. Neurology. 2009;72:968–973.
    1. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in Japanese. Brain. 2007;130:1206–1223.
    1. Takahashi T, Fujihara K, Nakashima I, et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain. 2007;130:1235–1243.
    1. Osoegawa M, Kira J, Fukazawa T, et al. Temporal changes and geographic differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler. 2009;15:159–173.
    1. Nakashima I, Fukazawa T, Ota K, et al. Two subtypes of optic-spinal form of multiple sclerosis in Japan: clinical and laboratory features. J Neurol. 2007;254:488–492.
    1. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485–1489.
    1. Sato D, Fujihara K. NMO without typical opticospinal phenotype. Mult Scler. 2010;16:1154–1155.
    1. Smith CH, Waubant E, Langer-Gould A. Absence of neuromyelitis optica IgG antibody in an active relapsing-remitting multiple sclerosis population. J Neuroopthalmol. 2009;29:104–106.
    1. Awad A, Hemmer B, Hartung HP, et al. Analysis of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis. J Neuroimmunol. 2010;219:1–7.
    1. Brettschneider J, Jaskowski TD, Tumani H, et al. Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases. J Neuroimmunol. 2009;217:95–101.
    1. Quintana FJ, Farez MF, Viglietta V, et al. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci U S A. 2008;105:18889–18894.
    1. Keller A, Leidinger P, Lange J, et al. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One. 2009;4:e7440.
    1. Frohman EM, Balcer LJ, Calabresi PA. Multiple sclerosis: can retinal imaging accurately detect optic neuritis? Nat Rev Neurol. 2010;6:125–126.
    1. Bø L, Vedeler CA, Nyland H, et al. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler. 2003;9:323–331.
    1. Bø L, Vedeler CA, Nyland HI, et al. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol. 2003;62:723–732.
    1. Geurts JJ, Pouwels PJ, Uitdehaag BM, et al. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology. 2005;236:254–260.
    1. Calabrese M, De Stefano N, Atzori M, et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol. 2007;64:1416–1422.
    1. Nelson F, Poonawalla A, Hou P, et al. 3D MPRAGE improves classification of cortical lesions in multiple sclerosis. Mult Scler. 2008;14:1214–1219.
    1. Nelson F, Poonawalla A, Hou P, et al. Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. Am J Neuroradiol. 2007;28:1645–1649.
    1. Calabrese M, Rocca MA, Atzori M, et al. Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology. 2009;72:1330–1336.
    1. Calabrese M, Rocca MA, Atzori M, et al. A 3-year magnetic resonance imaging study of cortical lesions in relapsing-onset MS. Ann Neurol. 2010;67:376–383.
    1. Filippi M, Rocca MA, Calabrese M, et al. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology. 2010;75:1988–1994.
    1. Wattjes MP, Harzheim M, Lutterbey GG, et al. Does high field MRI allow an earlier diagnosis of multiple sclerosis? J Neurol. 2008;255:1159–1163.
    1. Wattjes MP, Barkhof F. High field MRI in the diagnosis of multiple sclerosis: high field-high yield? Neuroradiology. 2009;51:279–292.
    1. Stankiewicz JM, Neema M, Alsop DC, et al. Spinal cord lesions and clinical status in multiple sclerosis: a 1.5 T and 3T MRI study. J Neurol Sci. 2009;279:99–105.
    1. Wattjes MP, Lutterbey GG, Gieseke J, et al. Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis. Am J Neuroradiol. 2007;28:54–59.
    1. Hammond KE, Metcalf M, Carvajal L, et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol. 2008;64:707–713.
    1. Mainero C, Benner T, Radding A, et al. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology. 2009;73:941–948.
    1. Kangarlu A, Bourekas EC, Ray-Chaudhury A, Rammohan KW. Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla. Am J Neuroradiol. 2007;28:262–266.
    1. Kollia K, Maderwald S, Putzki N, et al. First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. Am J Neuroradiol. 2009;30:699–702.
    1. Filippi M. In-vivo tissue characterization of multiple sclerosis and other white matter diseases using magnetic resonance based techniques. J Neurol. 2001;248:1019–1029.
    1. Rocca M, Agosta F, Sormani MP, et al. A three-year, multi-parametric MRI study in patients at presentation with CIS. J Neurol. 2008;255:683–691.
    1. LeBrunn C, Bensa C, Debouverie M, et al. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid and visual evoked potential. Arch Neurol. 2009;66:841–846.
    1. Sellner J, Schirmer L, Hemmer B, Mühlau M. The radiologically isolated syndrome: take action when the unexpected is uncovered? J Neurol. 2010;257:1602–1611.
    1. Okuda DT, Mowr EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009;72:800–805.
    1. Siva A, Saip S, Altintas A, et al. Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease. Mult Scler. 2009;15:918–927.
    1. Carmosino MJ, Brosseau KM, Arciniegas DB, Corboy JR. Initial evaluations for multiple sclerosis in a university multiple sclerosis center: outcomes and role of magnetic resonance imaging in referral. Arch Neurol. 2005;62:585–590.
    1. Sormani MP, Tintoré M, et al. The Will Rogers phenomenon in multiple sclerosis. Ann Neurol. 2008;64:428–433.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅